| Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis P Biswas, MM Hasan, D Dey, AC dos Santos Costa, SA Polash, S Bibi, ... Environmental Science and Pollution Research 28 (42), 59570-59593, 2021 | 59 | 2021 |
| Cordycepin as a promising inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) S Bibi, MM Hasan, YB Wang, SP Papadakos, H Yu Current Medicinal Chemistry 29 (1), 152-162, 2022 | 44 | 2022 |
| Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation AS Papazoglou, A Kartas, DV Moysidis, C Tsagkaris, SP Papadakos, ... Cardiovascular Diabetology 21 (1), 39, 2022 | 30 | 2022 |
| The role of the NLRP3 inflammasome in HCC carcinogenesis and treatment: Harnessing innate immunity SP Papadakos, N Dedes, E Kouroumalis, S Theocharis Cancers 14 (13), 3150, 2022 | 20 | 2022 |
| The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? SP Papadakos, K Arvanitakis, IE Stergiou, V Lekakis, S Davakis, ... Cancers 15 (10), 2795, 2023 | 17 | 2023 |
| The EPH/ephrin system in colorectal cancer SP Papadakos, L Petrogiannopoulos, A Pergaris, S Theocharis International Journal of Molecular Sciences 23 (5), 2761, 2022 | 17 | 2022 |
| The emerging role of metformin in the treatment of hepatocellular carcinoma: is there any value in repurposing metformin for HCC immunotherapy? SP Papadakos, D Ferraro, G Carbone, AE Frampton, G Vennarecci, ... Cancers 15 (12), 3161, 2023 | 16 | 2023 |
| Exosomes in the treatment of pancreatic cancer: a moonshot to PDAC treatment? SP Papadakos, N Dedes, A Pergaris, M Gazouli, S Theocharis International Journal of Molecular Sciences 23 (7), 3620, 2022 | 15 | 2022 |
| Nanotherapy based on magneto‐mechanochemical modulation of tumor redox state VB Orel, ΑS Papazoglou, C Tsagkaris, DV Moysidis, S Papadakos, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 15 (3 …, 2023 | 13 | 2023 |
| Investigating the anticancer potential of salvicine as a modulator of topoisomerase II and ROS signaling cascade D Dey, MM Hasan, P Biswas, SP Papadakos, RA Rayan, S Tasnim, ... Frontiers in oncology 12, 899009, 2022 | 13 | 2022 |
| The EPH/ephrin system in Pancreatic Ductal Adenocarcinoma (PDAC): from pathogenesis to treatment SP Papadakos, N Dedes, N Gkolemi, N Machairas, S Theocharis International Journal of Molecular Sciences 24 (3), 3015, 2023 | 11 | 2023 |
| COVID-19 and liver injury in individuals with obesity IG Lempesis, E Karlafti, P Papalexis, G Fotakopoulos, K Tarantinos, ... World Journal of Gastroenterology 29 (6), 908, 2023 | 11 | 2023 |
| Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation SP Papadakos, N Machairas, IE Stergiou, K Arvanitakis, G Germanidis, ... Cells 12 (16), 2036, 2023 | 8 | 2023 |
| Meeting at the crossroad between obesity and hepatic carcinogenesis: unique pathophysiological pathways raise expectations for innovative therapeutic approaches K Arvanitakis, SP Papadakos, V Lekakis, T Koufakis, IG Lempesis, ... International Journal of Molecular Sciences 24 (19), 14704, 2023 | 7 | 2023 |
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications SP Papadakos, IE Stergiou, N Gkolemi, K Arvanitakis, S Theocharis Cancers 15 (13), 3434, 2023 | 7 | 2023 |
| Onodera's prognostic nutritional index: Comparison of its role in the severity and outcomes of patients with COVID‑19 during the periods of alpha, delta and omicron variant … N Mathioudakis, M Zachiotis, S Papadakos, M Triantafyllou, A Karapanou, ... Experimental and Therapeutic Medicine 24 (5), 1-10, 2022 | 6 | 2022 |
| Angiogenesis in gastrointestinal stromal tumors: From bench to bedside SP Papadakos, C Tsagkaris, M Papadakis, AS Papazoglou, DV Moysidis, ... World Journal of Gastrointestinal Oncology 14 (8), 1469, 2022 | 6 | 2022 |
| Pill versus vaccine for COVID-19: Is there a genuine dilemma? SP Papadakos, N Mazonakis, M Papadakis, C Tsioutis, N Spernovasilis Ethics, Medicine, and Public Health 21, 100741, 2022 | 5 | 2022 |
| Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential K Arvanitakis, T Koufakis, G Kalopitas, SP Papadakos, K Kotsa, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 102935, 2023 | 4 | 2023 |
| Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics SP Papadakos, K Arvanitakis, IE Stergiou, C Vallilas, S Sougioultzis, ... Pharmaceutics 15 (10), 2460, 2023 | 4 | 2023 |
IOANNA E STERGIOUDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
